Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Patent
1995-12-26
1998-11-03
Duzo, David
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
4353201, 435364, C12N 15389, C12N 510, C12N 1586
Patent
active
058307273
ABSTRACT:
A novel HSV mini viral vector is disclosed. The vector comprises HSV and EBV genes which allow it to remain in episomal state, to have very high transfection and infection, and to tolerate up to 140 kb of foreign DNA. Techniques and genetic constructs for producing the vectors, for constructing the vectors and transfection and infection to recipient cells are disclosed.
REFERENCES:
patent: 4970155 (1990-11-01), Okasinski
patent: 5288641 (1994-02-01), Boizman
Orkin et al., "Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy", Dec. 7, 1995.
Geller, A., Nov. 1990, An Efficient Deletion Mutant Packaging System for Defective Herpes Simplex Virus Vectors: Potential Applications to Human Gene Therapy and Neuronal Physiology, Proc. Natl. Acad. Sci. USA, 87:8950-8954.
Glorioso, J., 1994, Development of Herpes Simplex Virus Vectors for Gene Transfer to the Central Nervous System, Gene Therapeutics: Methods and Applications of Direct Gene Transfer, Jon A. Wolff, Ed., Birkhauser Boston.
Spaete, R., Feb. 1985, The Herpes Simplex Virus Amplicon: Analyses of CIS-Acting Replication Functions, Proc. Natl. Acad. Sci. USA, 82:694-698.
Miyanohara, A., Mar. 1992, Direct Gene Transfer to the Liver with Herpes Simplex Virus Type 1 Vectors: Transient Production of Physiologically Relevant Levels of Circulating Factor IX, The New Biologist, 4(3): 238-246.
Spaete, R., Aug. 1982, The Herpes Simplex Virus Amplicon: A New Eucaryotic Defective-Virus Cloning-Amplifying Vector, Cell, 30:295-304.
Hammerschmidt, W., 1988, Identification and Characterization of oriLyt, A Lytic Origin of DNA Replication of Epstein-Barr Virus, Cell 55:427-433,
Kwong, A, Sep. 1984, Herpes Simplex Virus Amplicon: Effect of Size on Replication of Constructed Defective Genomes Containing Eucaryotic DNA Sequences, Journal of Virology, 51(3):595-603.
Johnson, P., May 1992, Cytotoxicity of a Replication-Defective Mutant of Herpes Simplex Virus Type 1, Journal of Virology, 66(5):2952-2965.
Geller, A., Sep. 1988, A Defective HSV-1 Vector Expresses Escherichia Coli .beta.-Galactosidase in Cultured Peripheral Neurons, Reports, 1667-1669.
Frankel, Niza, Minireview: The Herpes Simplex Virus Amplicon-A Virsatile Defective Virus Vector, pp. S40-S46 (written with support of the Israel Cancer Research Foundation, and the Israel Academy of Sciences).
Link, Jr. Charles J.
Wang Suming
Duzo David
Human Gene Therapy Research Institute
LandOfFree
Herpes simplex virus amplicon mini-vector gene transfer system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Herpes simplex virus amplicon mini-vector gene transfer system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herpes simplex virus amplicon mini-vector gene transfer system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-688370